Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism

ISME Journal

Volumn 8, Issue 11, 2014, Pages 2193-2206

  Tong, Maomeng ^a   McHardy, Ian ^a   Ruegger, Paul ^b   Goudarzi, Maryam ^c   Kashyap, Purna C ^d   Haritunians, Talin ^e   Li, Xiaoxiao ^e   Graeber, Thomas G ^a   Schwager, Emma ^f   Huttenhower, Curtis ^f   Fornace, Albert J ^c   Sonnenburg, Justin L ^d   McGovern, Dermot P B ^e   Borneman, James ^b   Braun, Jonathan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

glycan foraging; intestinal microbiome; microbial ecology; multi'omic analysis

Indexed keywords

ANTIGEN; DISEASE INCIDENCE; ENZYME ACTIVITY; FUNCTIONAL CHANGE; GENOME; METABOLISM; MICROBIOLOGY; RODENT; SECRETION;

FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; PROTEOME;

ADULT; AGED; ANIMAL; BACTERIUM; C57BL MOUSE; CROHN DISEASE; ENERGY METABOLISM; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INTESTINE MUCOSA; KNOCKOUT MOUSE; MALE; METABOLISM; METABOLOME; METAGENOME; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOUSE; RISK FACTOR;

ADULT; AGED; ANIMALS; BACTERIA; CROHN DISEASE; ENERGY METABOLISM; FEMALE; FUCOSYLTRANSFERASES; HUMANS; INTESTINAL MUCOSA; MALE; METABOLOME; METAGENOME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIOTA; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEOME; RISK FACTORS;

EID: 84908234204     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2014.64     Document Type: Article

References (74)

1. Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL et al. (2012). Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 8: e1002358.
2. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al. (2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
3. Benjamini Y, Hochberg Y. (1995). Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B Meth 57: 289-300.
4. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK et al. (2010). QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335-336.
5. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S et al. (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature 488: 178-184.
6. Claesson MJ, Wang Q, O'Sullivan O, Greene-Diniz R, Cole JR, Ross RP et al. (2010). Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res 38: e200.
7. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K et al. (2006). Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72: 5069-5072.
8. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent Met al. (2005). Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
9. Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C et al. (2012). Integrated metagenomics/ metaproteomics reveals human hostmicrobiota signatures of Crohn's disease. PLoS One 7: e49138.
10. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J et al. (2012). Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 8: e1002606.
11. Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, Blancher A et al. (2009). A natural history of FUT2 polymorphism in humans. Mol Biol Evol 26: 1993-2003.
12. Frank DN St, Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104: 13780-13785.
13. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H et al. (2011). Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 17: 179-184.
14. Friedman J, Alm EJ. (2012). Inferring correlation networks from genomic survey data. PLoS Comput Biol 8: e1002687.
15. Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E et al. (2011). Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest 121: 1657-1666.
16. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
17. Human Microbiome Project C (2012). Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.
18. Hurd EA, Holmen JM, Hansson GC, Domino SE. (2005). Gastrointestinal mucins of Fut2-null mice lack terminal fucosylation without affecting colonization by Candida albicans. Glycobiology 15: 1002-1007.
19. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB et al. (2008). Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4: 337-349.
20. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105: 15064-15069.
21. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY et al. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
22. Kashyap PC, Marcobal A, Ursell LK, Smits SA, Sonnenburg ED, Costello EK et al. (2013). Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci USA 110: 17059-17064.
23. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, Sakata K et al. (2004). Molecular cloning and characterization of Bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 186: 4885-4893.
24. Koren O, Knights D, Gonzalez A, Waldron L, Segata N, Knight R et al. (2013). A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol 9: e1002863.
25. Koropatkin NM, Cameron EA, Martens EC. (2012). How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10: 323-335.
26. Langfelder P, Horvath S. (2008). WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
27. Langfelder P, Zhang B, Horvath S. (2008). Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24: 719-720.
28. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA et al. (2013). Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31: 814-821.
29. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G et al. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
30. Lee YK, Mazmanian SK. (2010). Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330: 1768-1773.
31. Lepage P, Hasler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A et al. (2011). Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141: 227-236.
32. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H et al. (2008). Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105: 2117-2122.
33. Li X, LeBlanc J, Truong A, Vuthoori R, Chen SS, Lustgarten JL et al. (2011). A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface. PLoS One 6: e26542.
34. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. (2008). Mucins in the mucosal barrier to infection. Mucosal Immunol 1: 183-197.
35. Magalhaes A, Gomes J, Ismail MN, Haslam SM, Mendes N, Osorio H et al. (2009). Fut2-null mice display an altered glycosylation profile and impaired BabAmediated Helicobacter pylori adhesion to gastric mucosa. Glycobiology 19: 1525-1536.
36. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.
37. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U et al. (2013). Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 339: 1084-1088.
38. Martens EC, Lowe EC, Chiang H, Pudlo NA, Wu M, McNulty NP et al. (2011). Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol 9: e1001221.
39. McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M et al. (2010). Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet 19: 3468-3476.
40. McGuckin MA, Linden SK, Sutton P, Florin TH. (2011). Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9: 265-278.
41. McHardy I, Goudarzi M, Tong M, Ruegger P, Schwager E, Weger J et al. (2013). Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome 1: 17.
42. Metges CC. (2000). Contribution of microbial amino acids to amino acid homeostasis of the host. J Nutr 130: 1857S-1864S.
43. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13: R79.
44. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T et al. (2006). Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72: 1027-1033.
45. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S et al. (2013). Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502: 96-99.
46. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W et al. (2012). Host-gut microbiota metabolic interactions. Science 336: 1262-1267.
47. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG et al. (2012). Fucose sensing regulates bacterial intestinal colonization. Nature 492: 113-117.
48. Perez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K et al. (2012). Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62: 1591-1601.
49. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, Tlaskalova-Hogenova H et al. (2009). Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106: 15813-15818.
50. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
51. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60.
52. Raes J, Bork P. (2008). Molecular eco-systems biology: towards an understanding of community function. Nat Rev Microbiol 6: 693-699.
53. Rausch P, Rehman A, Kunzel S, Hasler R, Ott SJ, Schreiber S et al. (2011). Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 108: 19030-19035.
54. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E et al. (2010). Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11: 76-83.
55. Scheppach W. (1994). Effects of short chain fatty acids on gut morphology and function. Gut 35: S35-S38.
56. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J et al. (2013). Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339: 548-554.
57. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105: 16731-16736.
58. Sokol H, Seksik P. (2010). The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol 26: 327-331.
59. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN et al. (2010). Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141: 1241-1252.
60. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J et al. (2005). Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307: 1955-1959.
61. Spor A, Koren O, Ley R. (2011). Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9: 279-290.
62. Stewart JA, Chadwick VS, Murray A. (2005). Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. J Med Microbiol 54: 1239-1242.
63. Tattoli I, Sorbara MT, Vuckovic D, Ling A, Soares F, Carneiro LA et al. (2012). Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host Microbe 11: 563-575.
64. Tong M, Li X, Wegener Parfrey L, Roth B, Ippoliti A, Wei B et al. (2013). A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 8: e80702.
65. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al. (2009a). A core gut microbiome in obese and lean twins. Nature 457: 480-484.
66. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. (2009b). The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1: 6ra14.
67. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB et al. (2006). Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117-129.
68. Wacklin P, Makivuokko H, Alakulppi N, Nikkila J, Tenkanen H, Rabina J et al. (2011). Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One 6: e20113.
69. Willing BP, Gill N, Finlay BB. (2010). The role of the immune system in regulating the microbiota. Gut Microbes 1: 213-223.
70. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. (2006). Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40: 235-243.
71. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA et al. (2011). Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108.
72. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al. (2012). Human gut microbiome viewed across age and geography. Nature 486: 222-227.
73. Zhang B, Horvath S. (2005). A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4: Article17.
74. Zoetendal EG, Akkermans ADL, Akkermans-van Vliet WM, de Visser AGM, de Vos WM. (2001). The host genotype affects the bacterial community in the human gastronintestinal tract. Microb Ecol Health Dis 13: 129-134.